Prenetics Global Limited (PRE)
 NASDAQ: PRE · Real-Time Price · USD
 14.69
 +0.87 (6.26%)
  Oct 30, 2025, 1:38 PM EDT - Market open
Prenetics Global Revenue
Prenetics Global had revenue of $14.96M in the quarter ending June 30, 2025, a decrease of -2,737.31%. This brings the company's revenue in the last twelve months to $57.05M, up 256.82% year-over-year. In the year 2024, Prenetics Global had annual revenue of $30.62M with 40.83% growth.
Revenue (ttm) 
 $57.05M
Revenue Growth 
 +256.82%
P/S Ratio 
 3.14
Revenue / Employee 
 $200,179
Employees 
 285
Market Cap 
198.69M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 30.62M | 8.88M | 40.83% | 
| Dec 31, 2023 | 21.74M | 8.58M | 65.17% | 
| Dec 31, 2022 | 13.16M | 631.26K | 5.04% | 
| Dec 31, 2021 | 12.53M | -52.65M | -80.77% | 
| Dec 31, 2020 | 65.18M | 55.95M | 605.93% | 
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue | 
|---|---|
| UnitedHealth Group | 435.16B | 
| Johnson & Johnson | 92.15B | 
| Merck & Co. | 63.62B | 
| AbbVie | 58.33B | 
| AstraZeneca | 56.50B | 
| Novartis AG | 56.37B | 
| Eli Lilly and Company | 53.26B | 
| Novo Nordisk | 49.11B | 
PRE News
- 21 hours ago - Prenetics CEO Danny Yeung Publishes "The Dual-Engine Revolution" Manifesto: A Blueprint for the Future of Health + Wealth - GlobeNewsWire
- 1 day ago - Prenetics Announces Closing of Approx. $44.0 Million Equity Offering to Fuel IM8's Global Expansion and Bitcoin Treasury Strategy - GlobeNewsWire
- 3 days ago - Prenetics Announces Oversubscribed Approximately $48 Million Equity Offering with Potential for $216 Million in Total Proceeds to Fuel IM8's Global Expansion and Bitcoin Treasury Strategy - GlobeNewsWire
- 21 days ago - Prenetics: A Cautious Buy Based On Strong Sales Growth - Seeking Alpha
- 22 days ago - Prenetics' IM8 Launches Daily Ultimate Longevity, First Supplement to Target All 12 Hallmarks of Aging - GlobeNewsWire
- 4 weeks ago - Prenetics Announces CEO Danny Yeung Keynote at Token 2049 Singapore - GlobeNewsWire
- 6 weeks ago - Prenetics Announces Second Quarter 2025 Financial Results with IM8 on Track to Achieve $100M Annual Recurring Revenue by Year's End - GlobeNewsWire
- 4 months ago - World No. 1 Tennis Star Aryna Sabalenka Joins Prenetics' IM8 Health as Global Ambassador and Shareholder - GlobeNewsWire